Phase II trial of docetaxel and topotecan in recurrent and extensive small cell lung cancer

被引：0
|
作者：
Gormley, N
Edelman, MJ
Smith, R
Hausner, PF
Bedor, M
Bisaccia, S
机构：
[1] Univ Maryland, Greenebraum Canc Ctr, Baltimore, MD 21201 USA
[2] VA Maryland Hlth Care Syst, Baltimore, MD USA
来源：
LUNG CANCER | 2004年 / 46卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S42 / S43
页数：2
相关论文
共 50 条
  • [1] Phase II trial of weekly topotecan with docetaxel in recurrent small cell lung cancer (Aultman Lung 01)
    Khan, R. A.
    Hahn, B.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [2] A Phase I/II trial of topotecan in combination with cisplatin for extensive-disease small cell lung cancer
    Kubota, Kaoru
    Nishiwaki, Yutaka
    Yokoyama, Akira
    Sakai, Hiroshi
    Kiura, Katuyuki
    Segawa, Yoshihiko
    Ichinose, Yukito
    Ando, Masahiro
    Takeda, Koji
    Kudo, Shinzo
    Matsui, Kaoru
    Eguchi, Kenji
    Masuda, Noriyuki
    Shibuya, Masahiko
    Watanabe, Koshiro
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S815 - S815
  • [3] A phase II study of topotecan and docetaxel in patients with sensitive relapse small cell lung cancer
    Morgensztern, Daniel
    Perry, Michael C.
    Govindan, Ramaswamy
    ACTA ONCOLOGICA, 2008, 47 (01) : 152 - 153
  • [4] A phase I/II clinical trial of topotecan in combination with cisplatin for extensive-disease small cell lung cancer
    Seto, T.
    Ichinose, Y.
    Nishiwaki, Y.
    Kiura, K.
    Sakai, H.
    Shibuya, M.
    Takeda, K.
    Kudo, S.
    Eguchi, K.
    Watanabe, K.
    EJC SUPPLEMENTS, 2009, 7 (02): : 539 - 539
  • [5] A phase II trial of combination chemotherapy with topotecan and amrubicin in small cell lung cancer (SCLC).
    Nogami, N.
    Kiura, K.
    Takigawa, N.
    Harita, S.
    Chikamori, K.
    Shibayama, T.
    Tabata, M.
    Hotta, K.
    Shinkai, T.
    Tanimoto, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [6] Phase II trial of imatinib (I) and docetaxel (D) in recurrent non-small cell lung cancer (NSCLC)
    Huang, C. H.
    Williamson, S.
    Van Veldhuizen, P. J.
    Hsueh, C. T.
    Smith, H.
    Mayo, M.
    Allen, A.
    Kelly, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [7] A phase I/II trial of cisplatin, docetaxel and ifosfamide in advanced or recurrent non-small cell lung cancer
    Kunitoh, H
    Akiyama, Y
    Kusaba, H
    Yamamoto, N
    Sekine, I
    Ohe, Y
    Kubota, K
    Tamura, T
    Shinkai, T
    Kodama, T
    Goto, K
    Niho, S
    Nishiwaki, Y
    Saijo, N
    LUNG CANCER, 2001, 33 (2-3) : 259 - 265
  • [8] A Phase II Trial of Carboplatin and Weekly Topotecan in the First-Line Treatment of Patients with Extensive Stage Small Cell Lung Cancer
    Spigel, David R.
    Hainsworth, John D.
    Gandhi, Jitendra G.
    Gian, Victor G.
    Peyton, James D.
    West-Osterfield, Kimberly
    Clark, Bobby L.
    Vazquez, Elizabeth R.
    Jones, Suzanne F.
    Burris, Howard A., III
    Greco, F. Anthony
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (06) : 862 - 866
  • [9] A randomized phase II trial of oral topotecan versus docetaxel in the second-line treatment of non-small-cell lung cancer
    Jones, Suzanne
    Thompson, Dana
    Barton, John
    Patton, Jeff
    Shipley, Dianna
    Greco, E. Anthony
    Spigel, David
    Infante, Jeff
    Burris, Howard A., III
    CLINICAL LUNG CANCER, 2008, 9 (03) : 154 - 159
  • [10] Targeting cyclooxygenase-2 in recurrent non-small cell lung cancer: A phase II trial of celecoxib and docetaxel
    Csiki, I
    Morrow, JD
    Sandler, A
    Shyr, Y
    Oates, J
    Williams, MK
    Dang, T
    Carbone, DP
    Johnson, DH
    CLINICAL CANCER RESEARCH, 2005, 11 (18) : 6634 - 6640
12345